Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Pharmaxis delivers impressive Phase 2 clinical data to treat myelofibrosis, pushing on to FDA discussions
    • News

    Pharmaxis delivers impressive Phase 2 clinical data to treat myelofibrosis, pushing on to FDA discussions

    In a potential breakthrough for the field of bone marrow cancer treatment, biotech company Pharmaxis (ASX: PXS) has released the final interim data analysis of their Phase 2 clinical trials for PXS-5505, a promising drug aimed at combating the debilitating effects of myelofibrosis.  The data revealed 60% of trial patients experienced a significant improvement in

    Read More
    Public
  • Car subscription services on the rise as Carly reports 83% revenue rise
    • News

    Car subscription services on the rise as Carly reports 83% revenue rise

    In the current subscription economy (where everything from movie and music streaming to accommodation are available in the subscription model), even transportation services are joining the bandwagon. Car subscription services are becoming widely embraced especially among the younger demographic (aged 18-24), in which 69% of them would rather enjoy the benefit of having a car

    Read More
    Public
  • Toys R B‘us’t: Company struggles to raise capital after largest shareholder pulls out
    • News

    Toys R B‘us’t: Company struggles to raise capital after largest shareholder pulls out

    Toys retailer Toys R Us (ASX: TOY) has not had a playful history in Australia, having collapsed once in 2018, closing over 40 stores and laying off hundreds of employees. Then, it made a calculated comeback the very next year with the support of Hobby Warehouse (one of its largest shareholders), and in 2021, it

    Read More
    Public
  • US inflation under control?
    • Market Update

    US inflation under control?

    The XJO is expected to rally on open this morning following a strong move higher in the U.S last night on the back of lower than expected CPI. Their futures have also edged into the green. Yesterday we tested 7,150 resistance but shed our intraday gains as we waited for last night’s results. We settled

    Read More
    Public
  • Turning waste tyres into triumphs: Entyr records highest quarterly revenue in company’s history
    • News

    Turning waste tyres into triumphs: Entyr records highest quarterly revenue in company’s history

    Wondering what to do with your end-of-life car tyres? Recycle them so that they can become biofuel. (Who says only electric vehicles can win the climate change battle?) A report by the World Business Council for Sustainable Development found that a billion end-of-life tyres are generated every year, with four billion having already found their

    Read More
    Public
  • Sequoia Financial strengthens financial, legal, and accounting advice services through Castle acquisitions
    • News

    Sequoia Financial strengthens financial, legal, and accounting advice services through Castle acquisitions

    In a strategic move aimed at enhancing its comprehensive financial advice services, Sequoia Financial Group (ASX: SEQ), has announced the acquisition of Castle Corporate and Castle Legal. The deal is expected to bring substantial synergies to Sequoia’s operations,boost its earnings and bring benefits for Castle clients. Sequoia Financial has been at the forefront of providing

    Read More
    Public
  • «
  • ‹
  • 216
  • 217
  • 218
  • 219
  • 220
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.